As new waves of omicron infections continue to hit around the world, it’s becoming clearer that COVID is here to stay. As such, in the years to come, vaccination – both first courses and booster doses – will likely remain necessary to brace global communities against the worst health outcomes wrought by the virus.
But what if the current crop of vaccines could be improved? Recent advances in vaccine technology and delivery systems suggest there could be gains to be made.
